{
  "ticker": "KALV",
  "success": true,
  "price": {
    "current": 15.65,
    "currency": "USD",
    "day_high": 16.16,
    "day_low": 15.4,
    "52_week_high": 19.0,
    "52_week_low": 8.67
  },
  "market_cap": {
    "value": 791049472.0,
    "currency": "USD"
  },
  "shares_outstanding": 50546293.0,
  "volume": {
    "last": 650687,
    "average_30d": 1318515
  },
  "valuation": {
    "pe_ratio": null,
    "forward_pe": -7.7093596,
    "price_to_book": 46.57738
  },
  "company_info": {
    "name": "KalVista Pharmaceuticals, Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 339931000.0,
    "total_liabilities": 322932000.0,
    "stockholders_equity": 16999000.0,
    "cash": 243497000.0,
    "marketable_securities": 65661000.0,
    "total_liquidity": 309158000.0,
    "total_debt": 149585000.0,
    "long_term_debt": 139028000.0,
    "current_debt": 1429000.0,
    "error": null
  },
  "cash_flow": {
    "success": true,
    "period_date": "2025-07-31",
    "operating_cash_flow": -54502000.0,
    "free_cash_flow": -54939000.0,
    "investing_cash_flow": 21261000.0,
    "financing_cash_flow": 23210000.0,
    "error": null
  },
  "income_statement": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_expense": 58510000.0,
    "research_and_development": 11993000.0,
    "interest_expense": 4757000.0,
    "net_income": -49482000.0,
    "revenue": 13692000.0,
    "gross_profit": 12460000.0,
    "ebitda": -42568000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true,
    "has_cash_flow": true,
    "has_income_statement": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:48:37.408703",
    "url": "https://finance.yahoo.com/quote/KALV",
    "data_hash": "2c87cffa2d33ed26"
  }
}